Gschwendt M, Kittstein W, Horn F, Leibersperger H, Marks F
Deutsches Krebsforschungszentrum, Institut für Biochemie, Heidelberg, Federal Republic of Germany.
J Cell Biochem. 1989 Jul;40(3):295-307. doi: 10.1002/jcb.240400306.
The phosphorylation of an Mr 82,000 protein (p82) in the Triton X-100 extract of the particulate fraction of mouse epidermis is dependent on the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) or diacylglycerol and phospholipid and, contrary to protein kinase C (PKC)-catalyzed phosphorylation, cannot be activated by calcium plus phospholipid. The novel p82 kinase differs also from PKC in many other respects, such as substrate specificity, turnover rate, and sensitivity to inhibitors. The p82 kinase can be separated from PKC by chromatography on phenyl sepharose and does not react with a polyclonal PKC antiserum. Like PKC, the novel kinase phosphorylates its substrate on threonine and serine, but not on tyrosine. Similar to PKC, the epidermal p82-kinase system is down-modulated after TPA treatment of mouse skin, with a half-life of around 5 h. Down-modulation is also accomplished by the phorbol ester RPA, but not by the Ca2+ ionophore A23187, and it is inhibited by the immunosuppressive agent cyclosporin A. In addition to down-modulation, TPA treatment of the animals activates a phosphatase that dephosphorylates phosphorylated p82 in the extract of the particulate fraction.
小鼠表皮微粒体部分的Triton X - 100提取物中一种分子量为82,000的蛋白质(p82)的磷酸化依赖于佛波酯12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯(TPA)或二酰甘油和磷脂,并且与蛋白激酶C(PKC)催化的磷酸化相反,不能被钙加磷脂激活。这种新的p82激酶在许多其他方面也与PKC不同,如底物特异性、周转率和对抑制剂的敏感性。p82激酶可以通过苯基琼脂糖层析与PKC分离,并且不与多克隆PKC抗血清反应。与PKC一样,这种新激酶在苏氨酸和丝氨酸而非酪氨酸上磷酸化其底物。与PKC相似,经TPA处理的小鼠皮肤中表皮p82激酶系统会下调,半衰期约为5小时。佛波酯RPA也能实现下调,但钙离子载体A23187不能,并且它受到免疫抑制剂环孢素A的抑制。除了下调之外,对动物进行TPA处理还会激活一种磷酸酶,该磷酸酶使微粒体部分提取物中磷酸化的p82去磷酸化。